Global Autoimmune Disease Diagnostics Market Outlook Report to 2028, with Profiles of Abbott, Beckman Coulter, BioMerieux, Siemens Healthcare, F. Hoffmann-La Roche and Thermo Fisher Scientific

DUBLIN, Dec. 29, 2023 /PRNewswire/ — The “Autoimmune Disease Diagnostics: Global Markets” report has been added to  ResearchAndMarkets.com’s offering.

The global autoimmune disease diagnostics market was valued at nearly $14.2 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 3.9%, reaching $17.9 billion by 2028. A worldwide technological advancement in detecting autoimmune diseases fuels growth in this market.

In 2022, the enzyme-linked immunosorbent assay (ELISA) segment held the highest market share at about 31.5%, followed by Indirect immunofluorescence (IIF) at 26.4% and immunoblot at 20.2%.

This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.

The Report Includes

41 data tables and 30 additional tablesAn overview of the global market landscape related to the autoimmune disease diagnosticsIn-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028Evaluation of the current market size and revenue growth prospects specific to autoimmune disease diagnostics, accompanied by a comprehensive market share analysis categorized by technology, indication, gender, and geographical regionDetailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disordersDiscussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test resultsCoverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodiesCoverage of emerging technologies in autoimmune disease diagnostics, recent developments, future opportunities, patent review, and ESG trendsMarket share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategiesDetailed profiles of leading market participants, including Abbott, Beckman Coulter Inc., BioMerieux, Siemens Healthcare, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Market OutlookMarket Summary

Chapter 3 Market Overview and Definitions

Overview: Autoimmune Disease DiagnosticsEnzyme-|Linked Immunosorbent Assay (ELISA)Indirect Immunofluorescence (IIF)Multiplex ImmunoassaysWestern Blot (Immunoblot)Other TechnologiesIndicationsRheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Psoriatic ArthritisMultiple SclerosisInflammatory Bowel DiseaseThe Global Regulatory Structure for Autoimmune Disease DiagnosticsTest ValidationFDA Clearance or ApprovalGood Manufacturing Practices (GMP)Labeling and InstructionsPost-Market SurveillanceQuality Control and Quality AssuranceClinical Utility and Medical GuidelinesPrivacy and Data SecurityRegulatory Scenario

Chapter 4 Market Dynamics

Chapter 5 Market Breakdown by Region

Chapter 6 Market Breakdown by Gender

MaleFemale

Chapter 7 Market Breakdown by Indication

Type 1 DiabetesRheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Psoriasis/Psoriatic ArthritisMultiple SclerosisInflammatory Bowel Disease

Chapter 8 Market Breakdown by Technology

Enzyme-Linked Immunosorbent Assay (ELISA)Indirect Immunofluorescence (IIF)ImmunoblotMultiplex Immunoassays

Chapter 9 ESG Development

EnvironmentResearch PracticesSupply Chain SustainabilityWaste ManagementEnergy EfficiencySocialAccess to HealthcarePatient Well-BeingCommunity EngagementGovernanceEthical Business PracticesCompliance with RegulationsBoard DiversityTransparency and AccountabilityCase StudyRocheSustainability at RocheConcluding Remarks

Chapter 10 Emerging Trends and Technologies

Chapter 11 Competitive Landscape

Chapter 12 Patent Analysis

Chapter 13 Pipeline Analysis

Chapter 14 M&A and Venture Funding Outlook

Chapter 15 Company Profiles

AbbottBD BiosciencesBeckman CoulterBiomerieuxBio-Rad F. Hoffmann-La RocheQuest DiagnosticsSiemens HealthcareThermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/325lpk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-autoimmune-disease-diagnostics-market-outlook-report-to-2028-with-profiles-of-abbott-beckman-coulter-biomerieux-siemens-healthcare-f-hoffmann-la-roche-and-thermo-fisher-scientific-302023688.html

SOURCE Research and Markets